Titlebook: Leptin; Regulation and Clini Sam Dagogo-Jack, MD Book 2015 Springer International Publishing Switzerland 2015 Dysleptinemia.ELISA.Glucocort

hearken

書目名稱Leptin影響因子(影響力)




書目名稱Leptin影響因子(影響力)學(xué)科排名




書目名稱Leptin網(wǎng)絡(luò)公開度




書目名稱Leptin網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Leptin被引頻次




書目名稱Leptin被引頻次學(xué)科排名




書目名稱Leptin年度引用




書目名稱Leptin年度引用學(xué)科排名




書目名稱Leptin讀者反饋




書目名稱Leptin讀者反饋學(xué)科排名

不確定

Leptin Interaction with Brain Orexigenic and Anorexigenic Pathways,receptor gene or genes that impair the function of downstream leptin circuits in the brain, attenuated leptin receptor signal transduction, and brain inflammatory mechanisms. fMRI imaging studies suggest that similar mechanisms of leptin action operate in the human brain as has been established in r

可用

Physiological and Hormonal Factors that Influence Leptin Production,s, including insulin, glucocorticoids, growth hormone, estradiol, testosterone, insulin-like growth factor-I, and somatostatin also modulate leptin secretion. In addition to alteration of circulating leptin levels, evidence of an effect on leptin synthesis (as indicated by adipose tissue leptin mRNA

鋼盔

溫和女孩

Leptin in Acute Stress,g both increased insulin levels and an acute need for energy, blunts the insulin-induced rise in leptin or reduces leptin. While leptin is inconsistently affected by bouts of shorter duration exercise, prolonged endurance exercise acutely decreases leptin levels. During pregnancy, maternal leptin le

華而不實

課程

陳列

Dynamic Leptin Secretion in Obesity and Diabetes,betes. Healthy subjects respond with a doubling of plasma leptin levels following challenge with a single dose (1–4 mg) of dexamethasone, and also show ~50 % increase in leptin levels following infusion of insulin under clamped euglycemic conditions. Evaluation of dynamic leptin secretion across a w

生氣地

招惹

Leptin Therapy in People with a Normal Leptin Gene,h the pivotal metreleptin and PEG-OB randomized double-blind placebo-controlled studies showed modest but statistically significant weight loss in overweight and obese subjects at relatively high subcutaneously administered doses. A wide range of secondary outcomes were evaluated, although most repo